Table 4.
Neuropsychological data of patients with pure AD, AD with amygdala LP and AD with classical LP
| Subjects who had AD | ||||
| Without LP | Amygdala LP | Classical* LP | p | |
| Neuropsychological data | Mean (SD) | Mean (SD) | Mean (SD) | |
| First MMSE score | n = 16 | n = 7 | n = 10 | 0.81 |
| Score/30 | 18.6 (7.1) | 16.6 (6.7) | 17.8 (6.9) | |
| FAB | n = 10 | n = 5 | n = 7 | 0.52 |
| Score/18 | 9.6 (3.7) | 7.2 (2.9) | 8.6 (4.5) | |
| MDRS | n = 7 | n = 4 | n = 6 | 0.62 |
| Score/144 | 107.7 (17.7) | 111.3 (12.9) | 101.8 (13.3) | |
*neocortical, limbic and brainstem Lewy bodies. AD, Alzheimer disease; LP, Lewy pathology; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; MDRS, Mattis Dementia Rating Scale.